title: Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays.
authors.affiliation: Department of Dermatology, Archet 2 Hospital, Centre Hospitalier Universitaire (CHU) Nice, Nice, France.
authors.forename: Momen
authors.initials: M
authors.lastname: Pharaon
authors.affiliation: Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, Team 11, Centre Méditerranéen de Médecin Moléculaire (C3M), Nice, France.
authors.forename: Mélanie
authors.initials: M
authors.lastname: Tichet
authors.affiliation: Department of Neurology, Pasteur Hospital, CHU Nice, Nice, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Lebrun-Frénay
authors.affiliation: Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, Team 11, Centre Méditerranéen de Médecin Moléculaire (C3M), Nice, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Tartare-Deckert
authors.affiliation: Department of Dermatology, Archet 2 Hospital, Centre Hospitalier Universitaire (CHU) Nice, Nice, France4INSERM, U1065, Team 12, C3M, Nice, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Passeron
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002471:Cell Transformation, Neoplastic; D046169:Dermoscopy; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007155:Immunologic Factors / Q000494:pharmacology*; D039661:Integrin beta3 / Q000032:analysis; D008545:Melanoma / Q000737:chemistry / Q000473:pathology*; D009103:Multiple Sclerosis / Q000188:drug therapy; D000069442:Natalizumab; D009506:Nevus / Q000737:chemistry / Q000473:pathology*; D015676:Osteonectin / Q000032:analysis; D012878:Skin Neoplasms / Q000737:chemistry / Q000473:pathology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D039661:Integrin beta3; D000069442:Natalizumab; D015676:Osteonectin; C577241:SPARC protein, human